Previous close | 0.1850 |
Open | 0.1900 |
Bid | 0.1800 x 0 |
Ask | 0.1900 x 0 |
Day's range | 0.1900 - 0.1900 |
52-week range | 0.1400 - 0.2650 |
Volume | |
Avg. volume | 61,659 |
Market cap | 67.641M |
Beta (5Y monthly) | 1.33 |
PE ratio (TTM) | 12.67 |
EPS (TTM) | 0.0150 |
Earnings date | 23 Feb 2022 - 28 Feb 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental healthcare company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced participation in the following psychedelics research and industry conferences: